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Abstract 
During wound healing, endothelial progenitor cells (EPCs) are recruited from the 
bone marrow and directed to the site of injury. At the site of injury, hypoxic conditions 
promote TNF-α, which up regulates intercellular adhesion molecule-1 (ICAM-1). EPCs 
use ICAM-1 to attach to endothelial cells (ECs) lining blood vessels. Here, we design, 
develop and test a three-dimensional microbioreactor system (3-D MBR) with precise 
control and monitoring of oxygen and media flow rate. We first analyze the transport of 
oxygen in the proposed device. Following fabrication of the 3-D MBR, we next utilized a 
step-wise seeding technique, which resulted in confluency of human umbilical vein 
endothelial cells (HUVECs) on all four sides of the device. We next examine endothelial 
colony forming cell (ECFC) attachment and retention onto HUVECs using conventional 
2-D cultures. HUVECs are pre-stimulated with one of four conditions: 21% oxygen 
(atmospheric), atmospheric with TNF-α-supplemented media, 1% oxygen (hypoxia), and 
lastly hypoxia with TNF-α-supplemented media. We show the highest attachment and 
retention of ECFCs on HUVECs pre-treated with TNF-α and 1% oxygen, which 
correlated with the highest expression levels of ICAM-1. Using the new 3-D MBR 
system we next demonstrate that TNF-α and hypoxia, when used in conjunction, 
significantly increase EPC attachment on ECs under  pathologically relevant flow 
conditions. The 3-D MBR system allows us to mimic the oxygen and shear stress 
environment in the vasculature, thus providing a step between traditional in-vitro and in-
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 2-D Two-Dimensional 
3-D Three-Dimensional 
3-D MBR Three-Dimensional Microbioreactor 
c Concentration (M) 
D Diffusivity (cm^2/sec) 
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ECFCs Endothelial Colony Forming Cells 
EPC Endothelial Progenitor Cells 
Fn Fibronectin 
hc Height of the Channel in the 3-D Microbioreactor (μm) 
hm Height of the PDMS wall above and bellow the channel (μm)  
hmin Height of the channel (cm) 
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ICAM-1 Intercellular Adhesion Molecule-1 
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RT-PCR Reverse Transcriptase Polymerase Chain Reaction  
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Vasculogenesis is the growth of a primitive vascular network using endothelial cells 
(ECs) that have been differentiated from endothelial progenitor cells (EPCs)[1]. EPCs are 
immature endothelial cells originating from and stored in the bone marrow[2] with a high 
migratory nature[1]. EPCs are recruited from the bone marrow to the wound-healing site 
through paracrine signaling. At the wound site, damaged blood vessels limit blood flow and 
cause less oxygen to travel to the area of trauma (hypoxia)[3]. Hypoxia in the wound site 
can increase the demand for oxygen[4]. The hypoxic environment promotes an increased 
release of tumor necrosis factor- α (TNF-α), a pro-inflammatory cytokine that is secreted by 
injured vascular ECs. TNF- α signals inflammatory cells to migrate into the injury site in 
order to initiate the inflammatory phase[5]. TNF-α up regulates intercellular adhesion 
molecule-1 (ICAM-1), a transmembrane glycoprotein[6, 7] that binds to the beta-two-
integrins of EPCs[8].  ICAM-1 is present on a wide variety of cells types from ECs to 
leukocytes[7], and its expression level depends on the concentration of pro- and anti-
inflammatory mediators[7]. 
 When EPCs are stored in the bone marrow, they are in a relatively oxygen-poor 
environment that ranges from 1-7%[7]. The EPCs migrate through the blood stream in 
response to paracrine signaling factors, and become reoxygenated until they come in contact 
with the wound site. Wu et al.[9] examined EPC-EC interaction in both in vitro and in vivo 
models through the labeling of ICAM-1 and immunofluorescent tagging of EPCs. They 
were able to study EPC attachment and recruitment in an ischemic myocardium murine 
model. They demonstrated the necessity of a hypoxic environment in the recruitment of 
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EPCs for proper healing. Yoon et al[10] had a similar approach and were able to show the 
importance of ICAM-1 in EPC recruitment in a murine model for ischemic muscle tissue. 
However, as EPC attachment onto the wound site occurs under blood flow in hypoxic 
conditions, a biomimetic model that captures the role of hypoxia and shear stress is 
necessary to understand the mechanisms underlying the EPC recruitment to the wound-
healing site. 
Microfabrication has been used to generate advanced tissue culture systems that 
mimic different aspects in the in vivo microenvironment for several years. Microfabrication 
has been used to generate cellular matrix’s[11, 12] micropatterns of extracellular matrix 
protein[13, 14], and microfluidic devices [15].  In a review by Smith et al[16]  the authors 
look specifically at how microfluidics have been used to explore vascular tissue engineering, 
specifically angiogenesic pathways and how the extracellular environment affect vascular 
tissue. The ability to control both physical and chemical cues of the environments in 
microfluidics make it an ideal field through which to examine the key physiological and 
mechanical stimuli in the circulatory system such as oxygen concentration and shear stress.  
We have previously developed a microfluidic system that can adequately control 
oxygen tension independently from flow rate[17, 18]. This device prevents oxygen 
deviations along the channel, even at negligibly low shear stresses, to allow for maintaining 
cells in no shear conditions. Similarly, the channel height and the thickness of the upper 
polydimethylsiloxane (PDMS) wall were designed in a way to prevent the oxygen 
deviations across the channel height, allowing this system is to prevent uncontrolled oxygen 
gradients rather than creating them. This system also allows for long-term cell culture. In the 
current study, we modified the microbioreactor (MBR) system to allow for the three-
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dimensional (3-D) confluent cell coverage over a uniform substrate on all sides of the MBR, 
while maintaining uniform oxygen concentration throughout the 3-D MBR.  
 Using this model we were able to study the effects of various oxygen tensions with 
or without TNF- α stimulation during EPC attachment to ECs. In our experiments we used 
endothelial colony forming cells (ECFCs) as EPCs[19, 20], and human umbilical vein 
endothelial cells (HUVECs) for the endothelial lining of the device. We compared the 
conventional two-dimensional static culture (i.e. Petri dish) and 3-D dynamic model and 
found that both ECFC attachment to HUVECs and ICAM-1 expression in HUVECs increase 
significantly when the HUVECs were cultured under 0.05 mL/H flow, 1% oxygen, and 
stimulated with TNF- α.  
Goals 
 This first goal of this project was to develop a three-dimensional (3-D) 
microbioreactor to be used as an in-vivo mimicking model for vascular tissue in which 
oxygen tension and shear stress can be controlled independently from one another. Using 
this new system, we then explored EPC recruitment, attachment, and retention in a wound 
healing environment. We investigated the effect of hypoxia and TNF-α on ICAM-1 
expression and EPC recruitment in the 3-D MBR. 
Overall Approach 
The newly designed 3-D MBR was created to have one substrate present on sides of 
the reactor. This first modification enabled the seeding of cells onto a similar substrate on all 
four sides of the MBR. Second,  a novel three-dimensional seeding protocol was established 
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to efficiently and consistently allow confluent cell seeding on  all sides of the micro-
bioreactor. After establishing the protocol the new 3-D MBR was modeled using COMSOL 
to analyze the shear profile the cells experience as well as to confirm constant oxygen 
tension is constant throughout the MBR.  
With the MBR protocol established, we explored the effects of hypoxia and TNF-α 
regarding EPC recruitment. ICAM-1 plays a key role in the recruitment of EPC to 
endothelial cells [8-10]. We performed flow cytometry, reverse transcriptase polymerase 
chain reaction (RT-PCR), and immunofluorescence staining and  imaging to analyze ICAM-
1 expression on HUVECs. HUVECs were stimulated with the following: atmospheric 
conditions, atmospheric conditions with TNF-α  supplemented media, hypoxic conditions, 
and hypoxic conditions with TNF-α  supplemented media. ECFCs were seeded on HUVECs 
in one of the four above-referenced conditions and the retention and attachment of ECFCs to 
HUVECs was quantified in a two-dimensional petri dish model. These experiments were 





Polydimethlysiloxane (PDMS),is a silicone elastomer with many experimentally 
desirable properties. PDMS is chemically inert, thermally stable, and permeable to 
gasses[21]. One of the best benefits of utilizing PDMS is that it has the ability to fabricate 
microstructures. The polymer is also transparent and biocompatible.[21] In the field of 
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microfluidics PDMS has been developed to allow for a variety of applications: separations, 
patterning, and the creation of channels.[22] 
Poly(methyl methacrylate)  
Poly (methyl methacrylate) (PMMA) is an optically clear acrylic that has very low 
oxygen permeability (4.3×10−17 mol/s cm mmHg[23, 24]). This acrylic is used to fabricate 
the casing that surrounds the 3-D MBR and plays a key factor in allowing oxygen tension to 
be controlled independently from media flow rate.  
 
Microfabrication of 3-D Microbioreactor (3-D MBR) 
The 3-D MBR was fabricated using photolithography and soft lithography methods 
for the microfluidic device and machining methods for the O2 enclosure. The channel mold 
was fabricated using a negative photoresist (SU8-2100, Microchem Corporation, Newton, 
MA, USA). The O2 enclosure was fabricated with polydimethylmethacrylate (PMMA) 
sheets (9 mm thick; McMaster-Carr, Princeton, NJ, USA).  A single channel fluidic device 
of polydimethylsiloxane (PDMS) was made to be 250 μm in width and 250 μm in height, 




Figure 1: Microfabrication of MBR was performed using photolithography and softlithography. Photolthography 
was performed to create the channel mold, and softlithography was used to create PDMS replicas of the base and 
channel portions of the MBR. Blue is the photoresist that is used the photolithography process, green is the PDMS 
used to make the channel portion of the MBR, and red is used to make the PDMS used to make the base portion of 
the MBR.  
 At each end of the channel there was a 3 mm open circle port.  The PDMS was spin 
coated (in order to control for height) and then let to cure in situ. An additional layer of 
PDMS was also spun. We peeled off the cured PDMS, punched circular holes at both ends 
of the channel and removed the debris through sonication with isopropyl alcohol. The 
punched holes were used as inlet and outlet ports for the culture channel. The base layer of 
PDMS was placed on the glass slide. The channel and the glass slide covered with PDMS 
was exposed to mild O2 plasma and bonded together. Two additional blocks of PDMS was 
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partially cured using a different mixing ratio and bonded using O2 plasma on top of the inlet 
and outlet holes. These PDMS blocks act as supports for the inlet and outlet tubes. The 
entire device was cured overnight at 65°C under weight to form a monolithic PDMS 
structure (Figure 2).  
 
Figure 2: Microbioreactor Design: The Figure above is reproduced from Abaci et al and shows the enclosure and 
the microbioreactor.[17] 
 For the 1% oxygen experiments the microfluidic device was housed inside a PMMA 
enclosure. The bottom block contained a trench to hold the glass slide and has a window at 
the bottom so that high-magnification objectives can come in close proximity to the cells for 
inverted microscopy. The plates were screwed together to form an enclosure, and vacuum 
grease was used to make the chamber airtight.  
Mathematical Model of 3-D MBR 
 The parameters and assumptions used in Abaci et al[17] were used in our 
mathematical models. The estimated wall shear stress was calculated using equation 1[17].  




                                      (1) 
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In this equation τmin is the minimum shear stress at the channel wall, μ is the dynamic 
viscosity, Qmin is the volumetric flow rate, hmin is the minimum height, and w is the width of 
the channel.  
 The computational fluid dynamics module in COMSOL Multiphysics® 4.4 software 
was used to perform the numerical calculation of the shear stress distribution and oxygen 
concentration in the MBR. The 3-D MBR was created in the software and was the same 
dimensions as the bioreactor used in the experiments. An automatic generated fine mesh 
divided the entire fluid body into >30,000 elements. The velocity field was calculated 
following the Navier-Stokes equation for incompressible fluid at steady state, neglecting 
gravity: 
                                            𝜌(𝒖 ∗ ∇)𝒖 = ∇ ∗ [−p𝑰 +  μ(∇𝒖 + (∇𝒖)𝑇)]               (2) 
where ρ is the density, μ is the dynamic viscosity of the fluid, u is the vector of velocity in 
all three directions, p is the pressure, and ∇ is the gradient operator. The shear stress tensor 
in the X-Z direction of the plate was defined as: 






)             (3) 
For the oxygen diffusion modeling COMSOL was also used to model the oxygen 
concentration throughout the system. The parameters in Abaci et al[17] where used again 
with the addition of extra cell layers to the model. Oxygen concentration was calculated 
using the convection diffusion equation:  
                                            
𝑑𝑐
𝑑𝑡
= ∇ ∗ (𝐷∇𝑐) −  ∇ (𝑢𝑐) − 𝑅               (4) 
where c is the concentration of oxygen, D is the diffusivity, u is the average velocity, R is 
your species generation term and ∇ is the gradient operator.  In the mass transfer COMSOL 
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model a fine mesh was generated and the entire fluid body was divided into >10,000 
elements. In this model we used the cellular consumption of oxygen from Abaci et al.[25]  
 Cell Culture 
Human endothelial colony forming cells (ECFCs) (passages 6-10; Lonza, 
Walkersville, MD, USA) were cultured in dishes coated with type 1 collagen (Roche 
Diagnostics, Basel, Switzerland) in endothelial growth medium (EBM-2 Basal Medium 500 
mL; Lonza, Walkersville, MD, USA) and supplemented with EGM-2 BulletKit (Lonza, 
Walkersville, MD, USA). ECFCs were passaged every 3 to 4 days with 0.05% trypsin 
(Invitrogen, Grand Island, NY, USA).  
 Human umbilical vein endothelial cells (HUVECs) were cultured using endothelial 
growth medium (EGM; PromoCell, Heidelberg, Germany). The HUVECs (passaged 3-5; 
PromoCell) were passaged every 3 to 4 days in 0.05% trypsin (Invitrogen).  
Static ECFC Attachment Assay 
HUVECs were cultured in a six well plate until they reached confluency. Each plate 
was then treated in one of four conditions for 24 hours. The four conditions were 21% 
oxygen (atmospheric), atmospheric with 10 ng/mL TNF-α[14] dissolved in the media, 1% 
oxygen (hypoxia), or hypoxia with 10 ng/mL TNF-α dissolved in the media. ECFCs that 
were cultured to confluency and treated in 1% oxygen for 24 hours were passaged and 
labeled using a red membrane dye (PKH26 Red Fluorescent Cell Linker Kit; Sigma-Aldrich, 
St. Louis, MO, USA). The ECFCs were then re-suspended in 0.1% BSA in PromoCell 
media and seeded on top of the HUVEC monolayer. The cells were left to statically attach 
for 45 minutes and then were gently washed 3 times to assess the attachment of ECFCs to 
the HUVECs. Some samples were further washed (10 times) to assess the retention of the 
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ECFCs. The plates were then imaged using light and fluorescent microscopy and merged 
using ImageJ. For each condition ten fields were counted, and the average number of ECFCs 
attached was calculated. ECFC attachment in petri dish was graphed as the number of 
ECFCs per well in the different conditions. A t-test was used to assess the variability in the 
data. The average number of cells per field was plotted for each of the given conditions. 
3D Microbioreactor Preparation and Cell Culture 
3-D MBR preparation was performed as previously described[17, 18]. The device 
was cleared with 3 mL of 70% ethanol and 6 mL of phosphate-buffered saline (PBS). 50 
μg/mL of fibronectin (Fn) was flowed into the 3-D MBR manually (Sigma-Aldrich, St. 
Louis, MO, USA) and allowed to incubate at room temperature for 2 hours. The channel 
was then rinsed with PBS prior to cell seeding. HUVECs are then seeded into the 3-D MBR 
at a concentration of 4 million cells per milliliter by injecting through the media inlet port. 
The cells were then incubated for 3 hours at 37°C to promote attachment. Media perfusion 
was performed at a flow rate of 0.05mL/H for 24 hours. After 24 hours of media perfusion 
another 4 million cells per milliliter were injected through the media inlet port, and were left 
to attach for 3 hours at 37°C with the device placed upside-down. Media was then perfused 
through the device again at 0.05 mL/H for 24 hours. Finally, before proceeding with 
experiments the device was tested for proper cell attachment and morphology. The device 
also has the ability to be enclosed in an impermeable PMMA case, and the oxygen 
environment inside the 3-D MBR can be controlled. The PDMS acted as a highly permeable 
membrane and allow oxygen to diffuse through the top, bottom, and walls of the 3-D MBR 
independently from flow rate. 
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ECFC Attachment in 3-D Microbioreactor 
After the 3-D MBR had been prepared it was then treated in one of two conditions 
for 24 hours. The first condition had complete cell media flow through the 3-D MBR at 0.05 
mL/H, minimal flow rate to maintain cell culture[18], in a 21% oxygen environment 
(atmospheric). The second condition had complete cell media with 10 ng/mL of TNF-α flow 
into the device and in a 1% oxygen environment (hypoxia). ECFCs that had been pretreated 
in a 1% oxygen environment for 24 hours were then labeled using PKH26 red (Sigma 
Aldrich). The ECFC’s were re-suspended in PromoCell media with 0.1% BSA and set to 
flow into the microfluidic device at 0.118 mL/H[26] for 1 hour. This flow rate allows for us 
to pathologically mimic the pressure drop of an arteriole in the MBR. Attachment was then 
assessed using overlapped fluorescent and light microscopy images.  For each condition ten 
fields were counted, and the average number of cells attached on the top, bottom, and 
sidewalls was calculated, and is graphed as ECFC attachment to HUVECs in the 
microfluidic device. A t-test was used to assess the variability in the data. The average 
number of cells per field was plotted for each of the given conditions. 
Immunofluorescence Staining and Imaging 
ECFCs were labeled with PKH26 (Sigma-Aldrich) according to manufacturer’s 
instructions. For cell fixation and staining in the 3-D MBR all occurred at a flow rate 1 
mL/H. Cells were fixed by flowing 0.5 mL of 3.7% paraformaldehyde fixative and 
incubated for 15 minutes at room temperature. For staining cells were parabolized with a 
solution of 0.05% Triton-X for 10 minutes and washed with PBS. They were then incubated 
for 2 hours with primary antibody. The primary antibody used was for ICAM-1 (1:200; 
R&D Systems, Minneapolis, MN). Cells were then rinsed with PBS and incubated with anti-
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mouse IgG Cy3 conjugate (1:50; Sigma-Aldrich) for 1 hour. Certain samples were rinsed 
with PBS and incubated with Alexa Fluor 488 Phalloidin (1:40; Invitrogen) for 30 minutes 
and with 4-6-diamidino-2-phenylindole, DAPI, (1:1000; Roche Diagnostics) for 10 minutes. 
The labeled cells were examined using fluorescence microscopy (Axiovert, Carl Zeiss, 
Thornwood, NY, USA).  
We confirmed the uniform monolayer around the inner walls of the 3D MBR 
channels by confocal imaging. A z stack was taken and images were acquired every 10 μm 
and compiled using ImageJ to make the 3-D renderings and demonstrate uniform HUVEC 
coverage along the 2.5 cm length of the device.  
Flow Cytometry 
 HUVECs were treated in one of four conditions: 21% oxygen (atmospheric), 
atmospheric with 10 ng/mL TNF-α dissolved in the media, 1% oxygen (hypoxia), or 
hypoxia with 10 ng/mL TNF-α dissolved in media. The cells were then fixed and stained for 
ICAM-1 with primary and secondary antibodies (as detailed above) in PBS plus 0.5% 
saponin (Sigma). Analysis was carried out in a FacsCalibure flow cytometer (Becton 
Dickinson) and using corresponding IgG controls.  Data was analyzed using forward-side 
scatter plots to exclude dead cells. Cyflogic v1.2 was used to complete the flow cytometry 
analysis. 
RT-PCR 
 A two-step reverse transcription polymerase chain reaction (RT-PCR) was 
performed on HUVECs treated in one of four conditions; 21% oxygen (atmospheric), 
atmospheric with 10 ng/mL TNF-α dissolved in the media, 1% oxygen (hypoxia), or 
hypoxia with 10 ng/mL TNF-α dissolved in the media. An ICAM-1 primer was analyzed 
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using a comparative computerized tomography method (Applied Biosystems) to calculate 
the amplification between the samples. Β-actin was used as the reference gene. The values 
were then graphed and averaged with standard deviations. 
Graphs and Statistics 
All analyses were performed in triplicate samples for n=3 at least. Real-time RT-
PCR was also performed on triplicate samples (n=3) with triplicate readings. T-Tests or One 
Way ANOVA with Bonferroni post-hoc test was performed where appropriate to determine 
significance (GraphPad Prism 4.02). Graphed data is presented as average ±SD. 
Significance levels were set at: P<0.05; **P<0.01; ***P<0.001. 
Results 
3D Microbioreactor   
The purpose of this device is to maintain the previously described characteristics of 
monitoring and controlling oxygen tension at the cellular level[17, 18] as well as to allow 
for 3-D cell coverage on a uniform substrate, permitting oxygen diffusion through all sides 
of the device. Figure 3 shows the modifications that were made to the MBR. 
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Figure 3: The modification of the extra PDMS layer to the new 3-D device: hm is the thickness of the PDMS walls 
(650 μm) and hc is the height of the culture channel (250 μm). The channel is also 2.5 cm long. 
 
 A rectangular channel was used for the simplicity of fabrication that is 250 μm  tall 
(hc) and wide, as well as 2.5 cm long. The PDMS walls are 650 μm tall (hm). The use of the 
rectangular channel further allowed for equal coverage HUVECs with a simple seeding 
method, and without the use additional equipment. First, the shear stress profile was 
modeled using COMSOL (Figure 4).  
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Figure 4: Shear Stress in the MBR: COMSOL was used in order to model the shear stress in the 3-D 
MBR at a flow rate of 0.1 mL/H. 
 There is a single magnitude difference between the shear at the corners and the shear 
felt at the center of a wall.  There is a single magnitude increase in the shear  stress in the 
middle of the channel compared to the shear stress at the walls. At the corners of the channel 
there is 0 dyne/cm2 of shear. However, this only extends ~5 μm out from the corner of the 
MBR.  
We performed computer simulations using COMSOL Multiphysics on the initial 
design to show that uniform oxygen distribution can be achieved throughout the channel, at 
various flow rates of media through the device (Figure 5A-B).  
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Figure 5: 3-D MBR simulations and Design.  A COMSOL Multiphysics simulations showing percent the partial 
pressure of oxygen (atm) for the new 3-D  MBR design were run with 1% oxygen (hypoxia) (A) with 21% oxygen 
(atmospheric) (B) around the 3-D MBR (units are in atmospheres) . (C) Graph showing the concentration of oxygen 
versus the different x coordinates of the channel.  
This MBR allows for oxygen tension to be controlled independent of media flow 
rate. At both 1% O2 (Figure 5A) and 21% O2 (Figure 5B) the oxygen tension was uniform 
along the height and length of the channel (Figure 5C).  Once the basic parameters where 
established we continued with cell seeding in the channel.  
  We further developed a novel and time-efficient seeding method to obtain a 
confluent monolayer of HUVECs on all sides of the micro channel (Figure 6). 
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Figure 6: Seeding Protocol in MBR: Flow diagram of the seeding protocol for the 3-D MBR. 
 
We first used an autoclaved 3-D MBR, sterilized it using ethanol, and flowed high-
concentration fibronectin (Fn) into the device and let it sit statically at room temperature for 
2 hours to incubate, which allowed cell attachment on all four sides of the microfluidic 
channel.  Next we flowed in HUVECs by manual injection and let them statically attach for 
3 hours to form the initial monolayer of HUVECs.  The HUVECs were then cultured 
overnight to have the cells further anchor and spread in the device. The next day, a second 
seeding of HUVECs was performed in the device. The cells were flowed in at 5 mL/H using 
a syringe pump. The pump was used because it allowed for a quick delivery of cells without 
compromising the existing monolayer. We inverted the device and allowed the cells to settle 
and attach gravitationally. The cells were then cultured with the device inverted for 24 
hours, with constant media perfusion at 0.05 mL/H.  Finally the HUVECs in the 3-D MBR 
were cultured for a third day of constant media flow rate of 0.05 mL/H to allow cells to 
grow to confluency on the sides of the 3-D MBR. 0.05 mL/H is the minimal flow rate to 
culture HUVECs in this MBR with a height of 250 μm, as shown by Abaci et al[17]. Using 
this step-wise seeding approach, we achieved a quick and efficient way of having equal 
surface coverage of HUVECs in the 3-D MBR.  
We confirmed the uniform monolayer around the inner walls of the channel by 
confocal imaging (Figure 7). 
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Figure 7: Immunofluorescent images: Seeding photos (phalloidin in green, nuclei in blue) show the bottom (A); side 
(B); top (C); and orthogonal (D). 
We can see in that the bottom (Figure 7A), walls (Figure 7B) and top (Figure 7C) of the 3-D 
MBR were completely confluent. Orthogonal slice (Figure 7D) show the entire coverage of 
the device. Finally we used images that were taken every 10 μm and compiled the images 





Figure 8: 3-D MBR renderings of the front (A)  and cross-section (B)  of the whole 3-D MBR created using ImageJ 
and a confocal z stack with image slices taken every 10 μm. 
This demonstrates the uniform HUVEC coverage along the 2.5 cm length of the device  
(Figure 8A-B). Overall, the 3-D MBR device developed here allows for us to set up a 
pseudo-vasculature system with control over shear stress and oxygen tension.  
ICAM-1 Up Regulation by Hypoxia and TNF-α Mediates ECFC Attachment to 
HUVECs at Static Conditions 
To explore the utilization of our newly developed system to model EPC recruitment 
during wound healing, we first performed experiments in a static model. We cultured 
HUVECs on 35 mm petri dishes, coated with Fn, and allowed them to reach confluency. We 
hypothesized that ICAM-1 is the major adhesion molecule responsible for the attachment of 
ECFCs to HUVECs in wound healing model[1]. We first set out to find the optimal 
conditions to increase ICAM-1 levels. We cultured HUVECs in four different conditions; 
21% oxygen (atmospheric), atmospheric in media supplemented with 10 ng/mL TNF-α 
dissolved in the media, 1% oxygen (hypoxia), or hypoxia in media supplemented with 10 
ng/mL TNF-α. We found that hypoxia induces up regulation of ICAM-1 mRNA expression, 
as previously demonstrated [27, 28], while TNF-α  supplementation profoundly increases 
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the expression of ICAM-1 in both atmospheric and hypoxic atmospheric conditions (Figure 
9A). Specifically, HUVECs cultured under hypoxic conditions in media supplemented TNF-
α showed a 1000 fold increase in mRNA expression of ICAM-1 and the protein expression 
increased from 27.7% ± 8.1% (atmospheric) to 92.9% ± 0.6% (hypoxic conditions in media 
supplemented TNF-α (Figure 9A-C). 
 
Figure 9: PCR and Flow Cytometry Data of ICAM-1 Expression in HUVECs: HUVECs were stimulated in four 
different conditions: 21% oxygen (atmospheric), atmospheric with TNF-α-supplemented media, 1% oxygen 
(hypoxia) and hypoxia with TNF-α-supplemented media and were analyzed for ICAM expression using: (A) 
Quantitative RT-PCR, (B-C) flow cytometry (gray histogram is IgG control). ***P<0.001. 
This PCR and flow cytometry data show an up-regulation of ICAM-1 when hypoxia and 
TNF-α are used independently as well as synergistically. Immunofluorescent staining was 
performed to confirm ICAM-1 expression in the four different conditions (Figure 10A-D). 
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Figure 10: Immunofluorescent staining of ICAM-1 expression in HUVECs stimulated in four different conditions: 
21% oxygen (atmospheric), atmospheric with TNF-α-supplemented media, 1% oxygen (hypoxia) and hypoxia with 
TNF-α-supplemented media (ICAM-1 in red; nuclei in blue).  
From Figure 10 we can see that there is the most expression in HUVECs stimulated 
with both Hypoxia and TNF-α  (Figure 10D), when compared to the other three conditions 
(Figure 10A-C). ICAM-1 is used as the intracellular binding ligand to recruit EPCs to 
HUVECs[9] we can hypothesize that increased levels of TNF-α  expression and lowered 
levels of oxygen at the site of wound healing may increase EPC attachment through the 
stimulation of ICAM-1. 
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ECFCs attachment in static conditions 
To test this hypothesis, we examined ECFCs attachment onto HUVECs that were 
treated in one of the four conditions listed above. Figure 11 shows the flow diagram of the 
experimental set up. 
 
 
Figure 11: ECFC attachment protocol: Schematic of the experimental procedure and timeline of experiments 
performed in 2-D static conditions. 
 
ECFCs were pretreated in 1% oxygen (hypoxia) for 24 hours to mimic the 
physiological environment in the bone marrow, where these cells reside before they enter 
the blood stream[29]; ECFCs were then labeled (using red PKH26 dye), seeded and allowed 
to attach for 45 minutes, washed and then evaluated for adhesion to the HUVECs. Using red 
PKH26 dye we can identify and count the number of ECFCs attached to the HUVECs.  We 
first found that there is a clear increase in ECFC attachment to HUVECs, when HUVECs 
were stimulated with TNF-α, hypoxia, or both. In fact, there are double the amount of 
ECFCs attached when HUVECs were stimulated with TNF-α and hypoxia in comparison to 
the atmospheric HUVECs (Figure 12A-E).  
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Figure 12: ECFC attachment to HUVECs: (A-D) Fluorescence images overlapping light microscopy images and (F) 
quantification of ECFCs (red) attached onto HUVECs stimulated in one of the four different conditions. This was 
done with 3 washes to look at the attachment of ECFCs to HUVECs. P<0.05. 
 We also found an 80% ± 9% increase in attachment of ECFCs when they are seeded 
on HUVECs stimulated with hypoxia and TNF-α, compared to untreated (p value<0.01) 
HUVECs.    
For the EPCs to contribute to the vessel formation, they need to attach to the EC 
lining but then also need to remain attached and resilient to the shear forces applied by blood 
flow.  Therefore, we also evaluated the number of ECFCs that were more strongly attached 
on HUVECs in all conditions when washed. We found that HUVECs stimulated with both 
TNF-α and hypoxia had the best retention of ECFCs (Figures 13A-E).  
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Figure 13: ECFC retention to HUVECs: (A-D) Fluorescence images overlapping light microscopy images and (E) 
quantification of ECFCs (red) attached onto HUVECs stimulated in one of four different conditions after extended 
washing period. P<0.05; **P<0.01; ***P<0.001. 
There was a three-fold increase in attachment of ECFCs on HUVECs stimulated 
with hypoxia and TNF-α compared to atmospheric conditions. There was also a 48% ± 4.8% 
increase in ECFC attachment on HUVECs stimulated with only TNF-α and there was a 48%  
±20% increase in ECFC attachment on HUVECs stimulated with only hypoxia (Figure 
13E).  From this data, we observed a strong correlation between the increase in ICAM-1 
levels and the attachment and retention of ECFC in response to varying conditions. From 
these two-dimensional analogues we moved to the 3-D MBR. The 3-D MBR system is a 
useful tool to study the attachment and retention of ECFCs simultaneously at precisely 
controlled oxygen tension and shear forces.  
ECFC attachment on HUVECs in 3-D MBR 
Finally, we examined whether our newly developed 3-D MBR better mimics the 
wound healing microenvironment. Following the protocol described above (Figure 6), 
HUVECs were seeded in the 3-D MBR (as detailed in Figure 7 and 8) and grown in 
atmospheric conditions or stimulated with hypoxia and TNF-α supplemented media for 24 
hours at 0.05 ml/H. 0.05 mL/H is what was shown by Abaci et al, as the minimum flow rate 
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to sustain HUVEC survival in a MBR with this height[17]. ECFCs were pre-treated in 1% 
oxygen for 24 hours and then labeled with PKH26 red prior to being flowed through the 3-D 
MBR for 45 minutes at 0.118 mL/H [26] and in 21% oxygen. That flow rate was chosen to 
mimic the normal pressure drop that is seen in an arteriole of this size [26]. 0.118 mL/H is 
used to mimic the impaired blood supply normally observed at the wound site. Using the 
equations in Abaci et al, we have an average shear stress 0.1 dyne/cm2. [17]After the 45 
minutes the cells were imaged and counted as above. Having a constant flow rate of 1% 
oxygen into the PMMA chamber that is housing the MBR oxygen tension can be controlled. 
This constant flow of 1% oxygen has previously been used by Abaci et al to maintain 
oxygen tension in a similar device[17]. Using this bombardment method we can prevent 
oxygen gradients from forming in the MBR, and insure that there is uniform oxygen tension.  
We found that ECFC attachment to HUVECs in the 3-D MBR in atmospheric 
conditions was minimal (Figure 14A-C), with approximately the same amount of ECFCs 
attached to the top and bottom of the 3-D MBR (Figure 14C). 
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Figure 14: ECFC Attachment and retention on stimulated HUVECs in the 3-D MBR. ECFCs (red) were seeded on 
HUVECs stimulated in 21% oxygen (atmospheric) and imaged at the  bottom (A) and top (B) of the device and 
quantified (C). ECFCS were also seeded on HUVECs stimulated in hypoxia with TNF-α-supplemented media and 
imaged at the bottom (D) and top (E) of the device and quantified (F). P<0.05; **P<0.01; ***P<0.001. 
There was an increase in the average amount of ECFCs that were able to attach to HUVECs 
once they were stimulated with hypoxia and TNF-α at the top of the device (Figure 14D-E). 
Quantitative analysis revealed a ten-fold increase in the amount of ECFCs attached to the 
bottom of the device, and a ten-fold increase in the average number of ECFCs attached to 
the HUVECs stimulated with hypoxia and TNF-α when compared to atmospheric HUVECs 
(Figure 14C, F).  Moreover, in the hypoxic conditions with TNF-α, we observed preferential 
attachment of the ECFCs to the bottom layer of the microfluidic device compared to the top 
(Figure 14F). Due to the shear force acting on ECFC during the flow experiments, the 3-D 
MBR model takes into account both the attachment and retention of cells simultaneously, 
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and as such is more accurate than a static model.  Thus, the 3-D MBR allows for the 
assessment of ECFC recruitment in a more pathologically relevant microenvironment.  
Discussion  
The newly developed 3-D MBR allows for an in-vivo mimicking system. We first 
augmented the existing MBR reactor design by adding a base layer of PDMS (Figure 3). 
This base layer allows for the seeded ECs to be exposed to the same substrate on all sides of 
the system. This approach generated a rectangular channel, which simplified the fabrication. 
With this change we modeled the shear stress profile within the channel (Figure 4). We 
found that due to the rectangular design of the MBR there is a non-uniform shear stress at 
the corners. The shear stress at the walls of the system with a volumetric flow rate of 0.1 
mL/H is at 0.63 dynes/cm2, which is at pathological relevance for an ischemic wound. This 
allows us to properly mimic the flow rate and shear conditions of an ischemic wound. In a 
circular channel we also see a ten fold increase in the shear stress between the wall and the 
center of the channel (data not shown). However, at 0.1 mL/H a lower shear stress was 
achieved along the walls of the channel  (0.1 dynes/cm2), which is not pathologically 
relevant when compared to a square channel.  
In most conventional in-vitro culture systems, oxygen concentration is linked 
directly to the volumetric flow rate of the liquid flown through the 3-D MBR[30]. With the 
addition of a PDMS base layer to the rectangular 3-D MBR and a 3-D seeding of ECs, a 
COMSOL model was developed to study system-wide oxygen tension. As shown in Figure 
5, we found that the 3-D MBR allows for the precise control of oxygen tension and 
maintenance of uniform oxygen concentration along the length of the channel.  
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A new 3-D cell seeding protocol was also developed, which allowed for the 
complete coverage of the 3D-MBR. In our new approach we were able to efficiently seed 
HUVECs using a multistep seeding processes (Figure 6), which produces a fully confluent 
3-D MBR in 3 days.  This new system can be used to model different disease and injury 
states in order to study mechanisms and test the effectiveness of various drugs. 
Using this newly developed 3-D MBR we studied what factors contribute to the 
recruitment of circulating EPCs to ECs. ICAM-1 is the intracellular binding ligand that 
recruit EPCs to ECs[9]. Thus, we first analyzed ICAM-1 expression in HUVECs cultured in 
Petri dishes through RT-PCR, flow cytometry, and immunofluorescent staining. We cultured 
HUVECs in four different conditions; 21% oxygen (atmospheric), atmospheric in media 
supplemented with TNF-α dissolved in the media, 1% oxygen (hypoxia), or hypoxia in 
media supplemented with TNF-α. We found that hypoxia induces up regulation of ICAM-1 
mRNA expression, as previously demonstrated [27, 28], while TNF-α  supplementation 
profoundly increases the expression of ICAM-1 in both atmospheric and hypoxic 
atmospheric conditions. These trends hold true for both the RT-PCR and flow cytometry 
data, and the immunofluorescent images confirm these findings.  
We next hypothesized that increased levels of TNF-α expression and lowered levels 
of oxygen at the site of wound healing would increase ECFCs attachment through the 
stimulation of ICAM-1. We initially tested this hypothesis in petri dishes to assess the role 
of ICAM-1 in the adhesion of ECFCs to HUVECs. In this model we pre-treated the ECFCs 
in 1% oxygen to better mimic physiological conditions, while the HUVECs were treated in 
one of the four conditions mentioned above. The ECFCs were left to attach for 45 minutes 
and then washed with PBS. From this data we can see that TNF-α and hypoxia equally 
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increase the average number of ECFCs attached onto HUVECs. We also noted a slightly 
greater number of ECFCs attached when hypoxia and TNF-α were used together.  
However, when EPCs are released into the blood they need to attach to the site and 
then, furthermore, need to remain attached. From the experiments above it is clear that 
hypoxia and TNF-α used together increase attachment. However, we wanted to explore the 
strength of the attachment. We performed the same experiment above, except we increased 
the number of times the ECFCs were washed with PBS. From this retention trial we saw a 
greater number of ECFCs attached when HUVECs were stimulated with hypoxia and TNF-α 
when compared to other conditions, suggesting a stronger attachment under this condition.  
Our results are consistent with the previously shown role of ICAM-1 in EPC 
attachment[9]. In Wu et al., the authors showed that ICAM-1 is essential in EPC attachment 
through CD18 knockdown. They also showed that when CD18 is knockdown in vivo there 
is a 4-fold decrease in the amount of EPCs present. Carmona et al used an activated cAMP 
as a stimulator of ICAM-1[31] in order to increase EPC attachment and found a 50% ± 10% 
increase in baseline from their non-treated control[32]. In our study, when the HUVECs 
were stimulated with hypoxia, instead of cAMP, there was 154%± 34% increase of ECFC 
attachment compared to atmospheric HUVECs; and when HUVECs where stimulated with 
hypoxia and TNF-α there was a 272% ± 13% increase when compared to HUVECs in 
atmospheric conditions. In Carmona et al, also found that HUVECs treated with cAMP and 
TNF-α had a 50% ± 12% increase in the number of EPCs attached compared to pretreated 
with TNF-α only [32]. When this is compared to our results, we see stimulating HUVECs 
with TNF-α and hypoxia, there is a 50%±13% increase in ECFC attachment when compared 
to HUVECs just stimulated with TNF-α (Figure 13E). Although we were able to evaluate 
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the retention of ECFCs by mimicking shear with extended PBS washing, it should be noted 
that this method does not allow for accurately control of the shear forces applied on the 
ECFCs. This lead us to hypothesize that shear stress could play a role in assessing the 
attachment strength of ECFCs. The 3-D MBR system is a useful tool to study the attachment 
and retention of ECFCs simultaneously at precisely controlled oxygen tension and shear 
forces.  
In the 3-D MBR, HUVECs were stimulated with atmospheric conditions or with 
hypoxia and TNF-α supplemented media. In this model we found a significant increase in 
the number of ECFCs attached when the HUVECs were stimulated with hypoxia and TNF-
α. HUVECs stimulated in atmospheric conditions had an average of 4 ± 2 ECFCs attached, 
while HUVECs stimulated with hypoxia and TNF-α had an average of 35 ± 22 ECFCs 
attached. We also observed a preferential attachment of ECFCs to the bottom of the device, 
when compared to the top. In the atmospheric conditions there was a slight increase in the 
number of ECFCs attached to the bottom when compared to the top (Figure 14). However, 
HUVECs treated with hypoxia and TNF-α had two and a half times the number of ECFCs 
attached (Figure 14). The preferential attachment to the bottom of the channel is most likely 
due to gravity and the height of the channel. Due to the shear force acting on ECFCs during 
the flow experiments, the 3-D MBR model takes into account both the attachment and 
retention of cells simultaneously, and as such is more accurate than a static model. 
Comparing the 3-D MBR model (Figure 14) to the static 2-D, petri-dish model (Figure 13), 
we note that there were fewer ECFCs attached in the dynamic flow system. This 
phenomenon suggests fluid flow may play a role in the attachment of ECFCs during 
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recruitment to the wound site. Using the 3-D MBR we were able to better study the 
pathological environment of EPC attachment to ECs.  
Conclusion 
 
We were able to design and fabricate an improved MBR for the purpose of 3-D 
vascular modeling. The novel seeding method developed here allows for a quick and 
effective approach to generate a HUVEC monolayer on the top, bottom, and sidewalls of the 
device. In our model we control oxygen tension independently from flow rate. In our 3-D 
MBR system we were able to create an environment in which the ECs are exposed to the 
same substrate at all surfaces, and have sufficient oxygen diffusion on all sides of the device. 
These changes to the previous MBR design[17, 18] make the new 3-D MBR more 
pathologically relevant. We utilized the capabilities of the 3-D MBR system to study the 
recruitment of ECFCs in a wound-healing microenvironment. We first determined the 
optimal condition in which ICAM-1 is up regulated and then applied those conditions to the 
3-D MBR. When HUVECs were stimulated with hypoxia and TNF-α we found a significant 
increase in the number and retention rate of ECFCs. Importantly, ICAM-1 expression and 
ECFC attachment are further up regulated when TNF-α and a hypoxic environment. The 3-
D MBR allows for flow to be applied in the wound healing model and the ability to analyze 
the distribution of ECFC attachment when placed under shear stress. All dimensions of the 
system allow uniform oxygen tension at cellular level. Standard PDMS thicknesses and 
channel heights used in typical microfluidic systems would not allow this level of oxygen 
control. A limitation of the system is that the HUVECs aren’t pretreated with shear stress, 
which would more closely mimic the endothelial lining of the blood vessels. However, using 
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the same substrate on all sides of the 3-D MBR and the novel 3-D seeding method allow for 
a more pathologically relevant system, which can be used for in-vivo mimicking. This 
system can be used as a step between traditional in-vitro and in-vivo experimentation to 
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